[A case of sporadic amyotrophic lateral sclerosis (ALS) with Senataxin (SETX) gene variant]

Rinsho Shinkeigaku. 2022 Mar 29;62(3):205-210. doi: 10.5692/clinicalneurol.cn-001675. Epub 2022 Mar 25.
[Article in Japanese]

Abstract

A 67-year-old man presented slowly progressive weakness of the extremities visited our hospital. Nerve conduction study showed axonal neuropathy and needle electromyography showed neurogenic changes with denervation findings in multiple limb muscles. While he was diagnosed as Probable amyotrophic lateral sclerosis (ALS), which is defined by the Awaji criteria for diagnosis of ALS, he did not develop either respiratory muscle paralysis or bulbar palsy, which are characteristic symptoms of sporadic ALS. Genetic testing revealed a novel gene variant in senataxin (SETX), the causative gene of ALS4. We could not make a definite diagnosis of ALS4 because he had no relatives who could perform genetic testing (segregation study). However, we considered the variant can be pathogenic because it was not previously reported and absent in at least 1,000 healthy control individuals, the variant site was highly conserved in mammals, and it may impair the function of senataxin protein (in silico analysis).

Keywords: ALS4; SETX gene; familial amyotrophic lateral sclerosis; gene variant; senataxin.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Amyotrophic Lateral Sclerosis* / diagnosis
  • Amyotrophic Lateral Sclerosis* / genetics
  • Bulbar Palsy, Progressive*
  • DNA Helicases / genetics
  • Electromyography
  • Humans
  • Male
  • Multifunctional Enzymes / genetics
  • Muscle, Skeletal / pathology
  • RNA Helicases / genetics

Substances

  • Multifunctional Enzymes
  • SETX protein, human
  • DNA Helicases
  • RNA Helicases